US 7402673
Diamine β2 adrenergic receptor agonists
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7402673 (Diamine β2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P43/00